Immunohistochemical Nuclear Expression of ß-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer

Online journal article in Molecular Pathology that offers 1.0 continuing education (CME/SAM) credit that can be used to fulfill CC Part II requirements.

Write a Review

List Price: $20.00
Member Price: $15.00

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Join

Item Details:

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

list the four TCGA molecular groups of endometrial cancer with their prognostic significance, molecular signatures, and immunohistochemical surrogates.

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

list the four TCGA molecular groups of endometrial cancer with their prognostic significance, molecular signatures, and immunohistochemical surrogates.
describe the molecular group of endometrial cancer in which CTNNB1 exon 3 mutation has a prognostic value, and how it may affect the prognosis.
describe the possible application of immunohistochemistry for ß-catenin in the risk stratification of endometrial cancer, how it could be integrated in the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE), and how it could be interpreted.

View More View Less